Phil Johnson

Phil Johnson

Company: Interius BioTherapeutics

Job title: Chief Executive Officer


In Vivo Engineering of CAR-T & CAR-NK for Autoimmune Disease 11:30 am

Engineering T and NK cells directly in vivo to create antigen-specific CAR cells Bypassing and eliminating all aspects of ex vivo cell manufacturing Creating “faster, better, cheaper” autologous CAR cells without the need for chemotherapyRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.